Isomorphic Labs
Updated: May 14, 2026
CEO - Sir Demis Hassabis
Country: UK | Funding: $2.7B (+)
Founded: 2021
Website: https://www.isomorphiclabs.com
Isomorphic Labs is a spin-off of Google DeepMind, developing and designing drugs based on the AlphaFold platform, which predicts protein structures. The company has created powerful predictive and generative AI models that simulate complex biological phenomena to aid in the development of new molecules, predicting drug effectiveness, and creating innovative drugs to treat and cure some of the world's most devastating diseases. The company also provides scientists with the freely available AlphaFold Protein Structure Database, which gives open access to over 200 million protein structure predictions to accelerate scientific research.
Founded: 2021
Website: https://www.isomorphiclabs.com
Isomorphic Labs is a spin-off of Google DeepMind, developing and designing drugs based on the AlphaFold platform, which predicts protein structures. The company has created powerful predictive and generative AI models that simulate complex biological phenomena to aid in the development of new molecules, predicting drug effectiveness, and creating innovative drugs to treat and cure some of the world's most devastating diseases. The company also provides scientists with the freely available AlphaFold Protein Structure Database, which gives open access to over 200 million protein structure predictions to accelerate scientific research.
